Search
Now showing items 1-10 of 16725
Tocilizumab in COVID-19: Enthusiasm vs. evidence
(Wolters Kluwer Health, 2021)
Based on the pathophysiological characterization of COVID-19, initial studies suggested the use of tocilizumab (TCZ), a recombinant humanized monoclonal antibody of the immunoglobulin G1 class, for management of the cytokine ...
Improving the quality of Clinical and Biomedical Research
(HCPA/FAMED/UFRGS, 2014)
Characteristics and quality of clinical practice guidelines for depression in adults: A scoping review
(BioMed Central, 2019)
BACKGROUND: Clinical Practice Guidelines (CPGs) should follow an adequate methodology using an evidence-based approach in order to provide reliable recommendations. However, little is known regarding the quality of CPGs ...
Reviewers of Clinical and Biomedical Research - 2014
(HCPA/FAMED/UFRGS, 2015)
Strengthen disasters preparedness within clinical engineering-CE expertise and knowledge
(Springer, 2019)
Clinical Engineering supports the effectiveness of diagnosis and treatment; it also provides expert knowledge as health technology management, health technology planning, health technology assessment and other essential ...
Discriminating active from latent tuberculosis in patients presenting to community clinics
(Public Library of Science, 2012)
Background: Because of the high global prevalence of latent TB infection (LTBI), a key challenge in endemic settings is distinguishing patients with active TB from patients with overlapping clinical symptoms without active ...
Detection of Taenia solium DNA in the urine of neurocysticercosis patients
(American Society of Tropical Medicine and Hygiene, 2019)
Neurocysticercosis (NCC), caused by Taenia solium larvae that reside in the central nervous system, results in serious public health and medical issues in many regions of the world. Current diagnosis of NCC is complex ...